DIAMEDICA THERAPEUTICS INC's ticker is and the CUSIP is 25253X957. A total of 1 filers reported holding DIAMEDICA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6 | -45.5% | 2,500 | -66.2% | 0.00% | – |
| Q4 2022 | $11 | -99.9% | 7,400 | -19.6% | 0.00% | – |
| Q3 2022 | $11,000 | -21.4% | 9,200 | +29.6% | 0.00% | – |
| Q2 2022 | $14,000 | -44.0% | 7,100 | -29.0% | 0.00% | – |
| Q1 2022 | $25,000 | -55.4% | 10,000 | -33.8% | 0.00% | – |
| Q4 2021 | $56,000 | -51.7% | 15,100 | -44.5% | 0.00% | – |
| Q3 2021 | $116,000 | -3.3% | 27,200 | +0.4% | 0.00% | – |
| Q2 2021 | $120,000 | – | 27,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |